By An inflammatory molecule called LIGHT, appears to be the cause of life-threatening airway damage in patients with severe asthma. According to the new research from scientists at La Jolla Institute for Immunology (LJI), therapeutics to stop LIGHT (which is related to tumor necrosis factor) could reverse airway and lung damage in patients—and potentially offer a long-term treatment for asthma.
Researchers find missing piece of the asthma puzzle
smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.
Comments